Stevanato Group S.p.A.

NYSE:STVN

Medical - Instruments & Supplies

Healthcare
$15.36 +3.90%

+$0.67 today

Market cap
$4.20B
Beta
0.78
P/E (TTM)
29.9
EPS (TTM)
$0.52
Dividend yield
0.35%
52W Low $12.89High $28.00

Volume 0.61M

Average 0.52M

STVN Pre-Tax Margin

Income before tax as a percentage of revenue.

Stevanato Group S.p.A.NYSE: STVN

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin narrows to 12.6%

Pre-tax margin was 12.6% in Q2 FY2026, down 1.3 pp from a year earlier. On a trailing-twelve-month basis it was 15.7%, down 0.0 pp year over year. Over 3 fiscal years it narrowed by 3.1 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
12.6%-1.7 pp QoQ
Last fiscal yearDec 2025
15.9%+1.4 pp YoY
LTMJun 2026
15.7%-0.0 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.3 pp——
1 year+1.4 pp——
3 years-3.1 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
15.9%
Year-over-year change
+1.4pp

Pre-Tax Margin vs competitors

How STVN compares with its peers on the latest reported figures

  • STVN's LTM Jun 2026 pre-tax margin of 15.7% is the 2nd highest of the 10 companies compared; the peer median is 2.5%.
  • Its year-over-year change of -0.0 pp is the 6th highest of 10, against a peer median of +1.7 pp.
  • Over three fiscal years its change of -3.1 pp compares with a peer median of +1.7 pp.
STVN Competitors Peer median
Pre-Tax Margin for STVN and competitors
Company Period LTM level YoY 3-year change
MASIMasimo CorporationLTM Apr 202617.7% +31.5 pp+8.4 pp
STVNStevanato Group S.p.A.LTM Jun 202615.7% -0.0 pp-3.1 pp
CHEChemed CorporationLTM Jun 202614.2% -1.2 pp-1.4 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202613.1% +2.8 pp+4.1 pp
ATRAptarGroup, Inc.LTM Jun 202611.6% -2.1 pp+2.9 pp
BTSGBrightSpring Health Services, Inc. Common StockLTM Sep 20262.5% +1.7 pp+1.7 pp
BLCOBausch + Lomb CorporationLTM Jun 2026-1.2% +6.9 pp-8.2 pp
AVTRAvantor, Inc.LTM Jun 2026-7.2% -19.6 pp-18.1 pp
TFXTeleflex IncorporatedLTM Jun 2026-15.8% -23.9 pp-14.7 pp
AXSMAxsome Therapeutics, Inc.LTM Jun 2026-24.6% +25.4 pp+345.2 pp
NUVLNuvalent, Inc.FY2025— ——
Peer median (excluding STVN) 2.5%+1.7 pp+1.7 pp

Competitors are the stored peer set for STVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue843.92M983.68M1.09B1.1B1.14B
Cost of Revenue578.52M663.88M745.46M801.72M809.15M
Gross Profit265.41M319.8M339.89M302.32M330.33M
Gross Margin31.4%32.5%31.3%27.4%29.0%
Research & Development29.62M34.39M35.67M31.67M24.4M
Selling, General & Admin82.95M111.83M113.92M118.6M122.85M
Operating Expenses103.18M127.37M139.17M141.18M147.25M
Depreciation & Amortization56.38M64.82M78.48M80.65M88.57M
EBITDA226.93M256.4M272.35M247.8M292.01M
EBITDA Margin26.9%26.1%25.1%22.4%25.6%
Operating Income162.23M192.43M200.72M161.14M183.08M
Operating Margin19.2%19.6%18.5%14.6%16.1%
Interest Income548K648K792K1.72M12.49M
Interest Expense4.87M3.94M4.32M6.86M21.8M
Other Income / Expenses3.45M(4.79M)(11.17M)(854K)(1.44M)
Income Before Tax165.67M187.64M189.55M160.29M181.64M
Pre-Tax Margin19.6%19.1%17.5%14.5%15.9%
Income Tax Expense31.4M44.63M43.86M42.52M47.35M
Net Income134.32M142.85M145.63M117.78M134.28M
Net Margin15.9%14.5%13.4%10.7%11.8%
EPS (Basic)0.530.530.550.430.49
EPS (Diluted)0.530.530.550.430.49
Weighted Avg Shares264.7M264.7M264.95M272.87M273M
Weighted Avg Shares (Diluted)264.7M264.7M264.98M272.88M273M

Stevanato Group S.p.A.

NYSE:STVN

Intrinsic Alpha fair value

Locked

Current Price

$15.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.